Ras controls herpes virus penetration in cells
The molecular basis of host-cell permissiveness to herpes simplex viruses (HSV) is under intense investigation because of HSV prevalence in human disease and its potential use as an anti-cancer therapeutic. In the August issue of Nature Cell Biology, Faris Farassati and colleagues from the University of Calgary, Alberta, Canada show for the first time that oncogenes in Ras signalling pathway are essential in host-cell permissiveness to herpes simplex virus 1. These results may provide models for treating herpes virus infections, for example by downregulating the Ras pathway in infected cells. The authors also speculate that the association of herpes infections with cancers may be due to enhanced HSV permissiveness of cancer cells with an activated Ras signaling pathway.
